期刊文献+

Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease 被引量:5

在线阅读 下载PDF
导出
摘要 BACKGROUND Obesity is a risk factor for non-alcoholic fatty liver disease(NAFLD),although obese patients with NAFLD do not always develop significant fibrosis.The distribution of body fat could predict the risk of NAFLD progression.AIM To investigate the role of bioelectrical impedance-estimated visceral fat(VF)in assessing NAFLD severity.METHODS In this cross-sectional study,patients with biopsy-proven NAFLD were prospectively included.All patients underwent anthropometric evaluation,blood tests and bioelectrical impedance analysis.RESULTS Between 2017 and 2020,119 patients were included[66.4%male,56 years(SD 10.7),62.2%obese,61.3%with metabolic syndrome].Sixty of them(50.4%)showed significant fibrosis(≥F2)in liver biopsy.Age,VF and metabolic syndrome were associated with significant fibrosis(61 years vs 52 years,16.4 vs 13.1,73.3%vs 49.2%,respectively;P<0.001 for all).In the multivariate analysis,VF and age were independently associated with significant fibrosis(VF,OR:1.11,95%CI:1.02-1.22,P=0.02;age,OR:1.08,95%CI:1.03-1.12,P<0.01).A model including these variables showed and area under the receiver operating characteristic curve(AUROC)of 0.75,which was not inferior to transient elastography or NAFLD fibrosis score AUROCs.We developed a nomogram including age and VF for assessing significant fibrosis in routine practice.CONCLUSION VF is a surrogate marker of liver fibrosis in patients with NAFLD.Bioelectrical impedance analysis is an inexpensive and simple method that can be combined with age to guide patient referral when other resources may be unavailable.
出处 《World Journal of Gastroenterology》 SCIE CAS 2020年第42期6658-6668,共11页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献38

  • 1Li-Zhen Chen,Harry Hua-Xiang Xia,Yong-Ning Xin,Zhong-Hua Lin,Shi-Ying Xuan.TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease[J].Journal of Clinical and Translational Hepatology,2015,3(4):265-270. 被引量:6
  • 2Giovanni Tarantino,Carmine Finelli.Pathogenesis of hepatic steatosis:The link between hypercortisolism and non-alcoholic fatty liver disease[J].World Journal of Gastroenterology,2013,19(40):6735-6743. 被引量:19
  • 3Giovanni Tarantino,Carmine Finelli.What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?[J].World Journal of Gastroenterology,2013,19(22):3375-3384. 被引量:35
  • 4[1]Farrell GC,George J,Hall P,McCullough AJ.Overview:an introduction to NASH and related fatty liver disorders.In:Farrell GC,George J,Hall P,McCullough AJ,editors.Fatty liver disease.NASH and related disorders.Oxford:Blackwell Publishing,2005:1-12
  • 5[2]Chitturi S,Farrell GC,George J.Non-alcoholic steatohepatitis in the Asia-Pacific region:future shock? J Gastroenterol Hepatol 2004; 19:368-374
  • 6[3]Powell EE,Cooksley WG,Hanson R,Searle J,Halliday JW,Powell LW.The natural history of nonalcoholic steatohepatitis:a follow-up study of forty-two patients for up to 21 years.Hepatology 1990; 11:74-80
  • 7[4]Farrell GC.Non-alcoholic steatohepatitis:what is it,and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003; 18:124-138
  • 8[5]McCullough AJ.The epidermiology and risk factors of NASH.In:Farrell GC,George J,Hall P,McCullough AJ,editors.Fatty liver disease.NASH and related disorders.Oxford:Blackwell Publishing,2005:23-37
  • 9[6]Omagari K,Kadokawa Y,Masuda J,Egawa I,Sawa T,Hazama H,Ohba K,Isomoto H,Mizuta Y,Hayashida K,Murase K,Kadota T,Murata I,Kohno S.Fatty liver in non-alcoholic non-overweight Japanese adults:incidence and clinical characteristics.J Gastroenterol Hepatol 2002; 17:1098-1105
  • 10[7]Fan JG,Zhu J,Li XJ,Chen L,Lu YS,Li L,Dai F,Li F,Chen SY.Fatty liver and the metabolic syndrome among Shanghai adults.J Gastroenterol Hepatol 2005; 20:1825-1832

共引文献33

同被引文献21

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部